Author： Messina Silvia Patti Francesco
Publisher： Informa Healthcare
ISSN： 1742-5255
Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.10, 2013-10, pp. : 1349-1359
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Glatiramer acetate for the treatment of multiple sclerosis
Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. :
Access to resources
Recommend
Risk-Benefit Assessment of Glatiramer Acetate in Multiple Sclerosis
By Ziemssen T.
Drug Safety, Vol. 24, Iss. 13, 2001-01 ,pp. :
By Tsareva Ekaterina Y Kulakova Olga G Boyko Alexey N Shchur Sergey G Lvovs Dmitrijs Favorov Alexander V Gusev Evgeny I Vandenbroeck Koen Favorova Olga O
Pharmacogenomics, Vol. 13, Iss. 1, 2012-01 ,pp. :